Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 2/20 | 0.58 |
| ▸ | HTR1D | P28221 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.45 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.45 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1470314 | 0.95 | ALDH1A1 (0.60) | HTR1BHTR1DALDH1A1LMNAMAPT | |
| Pyridine SCHEMBL28502026 | 0.88 | HTR1B (0.54) | HTR1BHTR1DALDH1A1LMNAMAPT | |
| SCHEMBL7451259 | 0.82 | LMNA (0.58) | ALDH1A1LMNAMAPTHPGDSMN1; SMN2 | |
| SCHEMBL851166 | 0.82 | ALDH1A1 (0.66) | ALDH1A1LMNAMAPTHPGDSMN1; SMN2 | |
| SCHEMBL28403326 | 0.81 | HTR1B (0.58) | HTR1BHTR1DALDH1A1LMNAL3MBTL1 | |
| SCHEMBL11671997 | 0.81 | LMNA (0.61) | ALDH1A1LMNAMAPTHPGDSMN1; SMN2 | |
| SCHEMBL8204708 | 0.80 | ALDH1A1 (0.75) | ALDH1A1LMNAMAPTHPGDSMN1; SMN2 | |
| SCHEMBL8551794 | 0.80 | ALDH1A1 (0.69) | ALDH1A1LMNAMAPTHPGDSMN1; SMN2 | |
| SCHEMBL5090074 | 0.80 | ALDH1A1 (0.75) | ALDH1A1LMNAMAPTHPGDSMN1; SMN2 | |
| SCHEMBL23140741 | 0.80 | MTNR1A (0.69) | ALDH1A1LMNAMAPTHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111328280-A | Methods of making and using endoxifen | 阿托萨治疗学公司 | 2020-06-23 | — | — | CN | claimed |
| CN-116832020-A | Methods of making and using endoxifen | 阿托萨治疗学公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-111328280-A | Methods of making and using endoxifen | 阿托萨治疗学公司 | 2020-06-23 | — | — | CN | disclosed |
| CN-111212635-A | Topical compositions | 阿托莎医疗公司 | 2020-05-29 | — | — | CN | disclosed |
| CN-111212631-A | Topical compositions and methods of treatment | 阿托莎医疗公司 | 2020-05-29 | — | — | CN | disclosed |
| EP-3016947-A1 | BENZOTHIOPHENE DERIVATIVES AS ESTROGEN RECEPTOR INHIBITORS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2016-05-11 | — | — | EP | disclosed |
| WO-2015000867-A1 | BENZOTHIOPHENE DERIVATIVES AS ESTROGEN RECEPTOR INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2015-01-08 | — | — | WO | disclosed |
| CN-1471523-A | Imidazole derivatives as Raf kinase inhibitors | ʷ | 2004-01-28 | — | — | CN | disclosed |
| EP-0912567-B1 | CARBOLINE DERIVATIVES | ICOS CORP (US) | 2002-04-10 | — | — | EP | disclosed |
| US-6306870-B1 | PHOSPHODIESTERASE ENZYME INHIBITORS, CARDIOVASCULAR DISORDERS AND SEXUAL DISORDERS | ICOS CORPORATION | 2001-10-23 | — | — | US | disclosed |
| CN-1067071-C | Carboline derivatives | ICOS CORP (US) | 2001-06-13 | — | — | CN | disclosed |
| US-6117881-A | POTENT AND SELECTIVE INHIBITORS OF CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE SPECIFIC PHOSPHODIESTERASE | ICOS CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
| US-6043252-A | A POTENT AND SELECTIVE INHIBITORS OF CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE SPECIFIC PHOSPHODIESTERASE (CGMP-SPECIFIC PDE); TREATING CARDIOVASCULAR DISORDERS AND ERECTILE DYSFUNCTION | ICOS CORPORATION (US) | 2000-03-28 | — | — | US | disclosed |
| CN-1218471-A | Carboline derivatives | ICOS CORP (US) | 1999-06-02 | — | — | CN | disclosed |
| EP-0912567-A1 | CARBOLINE DERIVATIVES | ICOS CORPORATION (US) | 1999-05-06 | — | — | EP | disclosed |
| WO-1997043287-A1 | CARBOLINE DERIVATIVES | ICOS CORPORATION (US) | 1997-11-20 | — | — | WO | disclosed |